At close: 3:45:01 PM GMT+9
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 3 |
| Avg. Estimate | -- | -- | 300M | 1.59B |
| Low Estimate | -- | -- | 300M | 1.27B |
| High Estimate | -- | -- | 300M | 2B |
| Year Ago Sales | -- | -- | 121M | 300M |
| Sales Growth (year/est) | -- | -- | 147.93% | 431.67% |
Earnings History
| Currency in JPY | 12/31/2023 | 3/31/2024 | 9/30/2024 |
|---|---|---|---|
| EPS Est. | -14.63 | -4.96 | -11.63 |
| EPS Actual | -24.43 | -29.05 | -17 |
| Difference | -9.8 | -24.09 | -5.37 |
| Surprise % | -66.99% | -485.69% | -46.17% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4593.T | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
4592.T SanBio Company Limited
770.00
-0.52%
AFFY Affymax, Inc.
0.0024
0.00%
ATHXQ Athersys, Inc.
0.0000
0.00%
TVGNW Tevogen Bio Holdings Inc.
0.0750
-5.66%
BRNS Barinthus Biotherapeutics plc
1.0400
-8.77%
AKTX Akari Therapeutics, Plc
1.2100
-5.47%
ALVR AlloVir, Inc.
0.4599
+2.25%
PSTV Plus Therapeutics, Inc.
1.2000
0.00%
ALRN Aileron Therapeutics, Inc.
2.0200
+4.66%
EDSA Edesa Biotech, Inc.
1.8400
+2.22%